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Accurate prediction of survival rates of cancer patients is often key to stratify patients for prognosis and treatment. Survival
prediction is often accomplished by the TNM system that involves only three factors: tumor extent, lymph node involvement, and
metastasis. This prediction from the TNM has been limited, because other potential prognostic factors are not used in the system.
Based on availability of large cancer datasets, it is possible to establish powerful prediction systems by using machine learning
proceduresandstatisticalmethods.Inthispaper,wepresentanensembleclustering-basedapproachtodevelopprognosticsystems
of cancer patients. Our method starts with grouping combinations that are formed using levels of factors recorded in the data. The
dissimilarity measure between combinations is obtained through a sequence of data partitions produced by multiple use of PAM
algorithm. This dissimilarity measure is then used with a hierarchical clustering method in order to ﬁnd clusters of combinations.
Prediction of survival is made simply by using the survival function derived from each cluster. Our approach admits multiple
factors and provides a practical and useful tool in outcome prediction of cancer patients. A demonstration of use of the proposed
method is given for lung cancer patients.
Copyright © 2009 Dechang Chen et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Accurate prediction of outcomes or survival rates of cancer
patients is often key to stratify patients for prognosis and
treatment. Outcomes of patients are usually generated using
standard survival functions and various factors recorded
in the database (such as SEER [1]o rN C D B[ 2]) that
have prognostic potential. All prognostic factors become
integrated through determination of the outcome according
to the survival rate. This integration leads to a prognostic
system that can be used to predict outcomes of any new
patients. Clearly, a crucial question is how can one form
a powerful prognostic system for cancer patients? The
traditional answer to this question is to use the TNM system
[3] that involves only three factors: tumor extent, lymph
node involvement, and metastasis. However, the outcome
prediction from the TNM has been limited, mainly because
any other potential prognostic factors are not used in the
system.
In this paper, we propose a computer-based prognostic
system for cancer patients that admit multiple prognostic
factors. Here is idea of our approach: (i) we partition
patientsfromacancerdatasetinto“natural”groupssuchthat
patients in the same group are more similar in survival than
patients from diﬀerent groups; (ii) once “natural” groups are
obtained,asurvivalfunctionforeachgroupcanbeestimated
by a standard method. Our prognostic system then consists
of groups of patients and survival functions associated with
the groups.
The ﬁrst step (i) is the key to the entire process.
Mathematically,thisstepisequivalenttoperformingacluster
analysis on a cancer dataset. However, this type of cluster2 Journal of Biomedicine and Biotechnology
analysis is diﬀerent from traditional clustering approaches,
which may be elaborated below. Suppose, after some simple
management, a typical record for a patient contained in a
cancer dataset is of the form: X,X1,...,Xm,w h e r eX is the
recorded patient’s survival time, which can be a censored
time, and X1,...,Xm a r em e a s u r e m e n t sm a d eo nm risk
factors or variables such as tumor size, gender, and age.
Cluster analysis rising in (i) means that clusters of patients
are sought such that patients in the same cluster are more
similar in their lifetime T than patients from diﬀerent
groups. Here the connection between T and the observed
time X is described as follows: T = X if X is an actual time
to death due to the cancer under study; T>Xotherwise
(in this case X is a censored time). Therefore, cluster analysis
from (i) is not equivalent to partitioning the set of vectors
{(X,X1,...,Xk)} or the set {(X1,...,Xk)} which could be
suggested by traditional clustering methods.
The above discussed diﬀerence between the cluster
analysis in (i) and the traditional clustering indicates that
clustering required in (i) may not be a trivial task. Other
potential challenges in accomplishing (i) include presence of
a high percentage of censored observations, diﬀerent types
of risk factors or variables, and a large dataset size [4–6]. For
example, an SEER dataset of lung cancer patients diagnosed
from 1973 through 2002 has more than 500000 patients,
comprises more than 30% records with censored survival
times, and involves more than 80 variables that are either on
the continuous, or ordinal, or nominal scale.
To overcome the above mentioned possible diﬃculties,
we consider subsets of a cancer data, based on combinations
of levels of some known key factors. This reduces the
complexity in establishing prognostic systems. We then
group these subsets by a hierarchical clustering algorithm,
where the distance measure between two subsets is learnt
through multiple clustering based on Partitioning Around
Medoids (PAM) of Kaufman and Rousseeuw [7].
The rest of the paper is organized as follows. In Section 2,
we brieﬂy review some necessary elements of clustering and
survival analysis. In Section 3, we present our algorithm of
clustering of cancer data. An application of our algorithm to
establishing a prognostic system for lung cancer patients is
provided in Section 4. And ﬁnally our conclusion is given in
Section 5.
2. Some Elements of Clusteringand
SurvivalAnalysis
Clustering may be viewed as a process of ﬁnding natural
groupings of objects. Commonly used clustering procedures
fall into two categories: partitioning approaches and hierar-
chical approaches. A partitioning approach assigns objects
into a group or cluster through optimizing some criterion.
A hierarchical approach produces a hierarchy of groups
or clusters. In this paper, we will use the PAM algorithm
(a partitioning algorithm) and linkage methods (special
cases of Hierarchical clustering techniques). They will be
brieﬂy reviewed in this section. Also reviewed in this section
are some notations of censoring and survival functions.
Censored survival times often occur in a cancer dataset and
represent on type of incomplete data. A survival function
providesaprobabilityofsurvivaltocertaintimesforacancer
patient.
2.1. PAM. Partitioning is one of the major clustering
approaches. PAM is a partitioning method operating on
a dissimilarity matrix, a matrix of pairwise dissimilarities
or distances between objects. It starts from selecting initial
K (a predetermined number) representative objects, or
medoids, assigning each data object to the nearest medoid,
and then iteratively replaces one of the medoids by one
of the nonmedoids which leads to a reduction in the sum
of the distances of the objects to their closest medoids.
The similarity measure here includes, as a special case,
the Euclidean distance, which is used with the K-means
algorithm. PAM is more robust than the K-means approach,
because it employs as cluster centers the medoids not the
means, and minimizes a sum of dissimilarities instead of a
sum of squared Euclidean distances.
2.2. Linkage Methods. Hierarchical clustering procedures are
the most commonly used clustering methods in practice.
Commonly used linkage methods include single linkage
(SL), complete linkage (CL), and average linkage (AL). They
are special cases of agglomerative clustering techniques,
operate on a given dissimilarity matrix, and follow the same
procedure beginning with the individual objects, at each
intermediate step two least dissimilar clusters are merged
into a single cluster, producing one less cluster at the
next higher level [8]. The diﬀerence among the linkage
methods lies in the dissimilarity measures between two
clusters, which are used to merge clusters. SL, CL, and AL
deﬁne, respectively, the dissimilarity between two clusters
to be the minimum distance between objects from these
two clusters, the maximum distance between objects from
these two clusters, and the average distance between objects
in the two clusters. The output of a linkage method is
often summarized into a plot where the nested clusters are
graphically represented as a tree, called a dendrogram. The
branches in the tree represent clusters. Two clusters merge
at a height along a dissimilarity axis that is equal to the
dissimilarity between the two clusters.
2.3. Censoring. Cancer data are often time-to-event data
that present themselves in diﬀerent ways, imposing great
challenges in analysis. One special feature of a large cancer
data set is censoring [9]. Censored observations come from
the mechanism of monitoring the progress of patients
from some point in time, such as the time a surgical
procedure is performed or a treatment regimen is initiated,
until the occurrence of some predeﬁned event such as
death. Censoring comes in many diﬀerent forms and right
censoringiswidelyusedinclinicalstudies.Rightcensoringis
usedtorecordtheamountoftimeelapsingbetweenthepoint
at which the patient entered the study and the point at which
he or she experienced one of the following three events: the
event of interest (e.g., death for most of the cancer studies);Journal of Biomedicine and Biotechnology 3
loss to follow-up for some reason such as death caused by
a health problem other than the one being considered or
having moved to another locality; alive at the time the study
is terminated. The time elapsing between enrollment in the
study and experiencing one of these three events is called
t h ep a t i e n t ’ ss u r v i v a lt i m e .As u r v i v a lt i m ei sc e n s o r e di fi t
is not the actual time between enrollment and experiencing
the event of interest. Given a censored survival time for a
patient, all we know about the lifetime of the patient is that it
is greater than some value. Censored survival times provide
only a portion of information on the actual lifetimes.
2.4. Survival Function. A patient’s lifetime T is a random
variable having a probability distribution. In addition to
the commonly used probability density function, the dis-
tribution of T can also be characterized by the survival
function, deﬁned to be S(t) = P(T>t ). The function S(t)
provides the probability of surviving beyond t.T h es u r v i v a l
function is usually estimated by a nonparametric method
referred to as the Kaplan-Meier estimator [10]. An estimated
survival function may be portrayed visually in a survival
curve graph. A direct comparison of several survival curves
can be conducted by examining the curves appearing in a
single graph. A theoretical comparison of several survival
functions can be made by conducting a commonly used test
such as the log-rank test, Gehan’s test [11], Breslow’s test
[12], and test of Tarone and Ware [13].
3. Algorithm of Clusteringof Cancer Data
A key issue related to clustering is how one measures the
dissimilarity between objects. Most clustering algorithms
presume a measure of dissimilarity. For example, the K-
means clustering uses Euclidean distance as a dissimilarity
measure. Since cancer data involve censored survival times, a
direct use of existing clustering algorithms is not applicable.
With cancer data, it is important to ﬁnd a way to deﬁne
objects and dissimilarity between objects prior to execution
of any clustering algorithm.
Suppose,foracancerdataset,acertainnumberoffactors
have been selected for consideration. Various combinations
can then be formed by using levels of factors. Speciﬁcally, a
combination is a subset of the data that correspond to one
level of each factor. Suppose there are available a total of N
combinations x1,x2,...,xn. A combination plays a role of an
object in the cluster analysis. When developing a prognostic
system, we need to ﬁnd groups of patients such that patients
within each group are more similar in survival than patients
from diﬀerent groups. Assuming that all patients coming
from the same combination have a similar survival rate, then
this is equivalent to ﬁnding natural groups of combinations.
After objects become available, we can start to deﬁne a
dissimilarity measure between objects. A dissimilarity mea-
sure dis(xi,xj) is a nonnegative function that is symmetric
with respect to xi and xj. For cancer data, a direct method
is to deﬁne the dissimilarity between two combinations
in light of the diﬀerence between the two corresponding
survival functions, and the details follow below. Given two
combinations xi and xj, testing if there is a diﬀerence
between the corresponding two survival functions can be
done by conducting a commonly used test such as the log-
rank test. It is known that a smaller value of a test statistic
shows a stronger evidence of no diﬀerence. Thus we can
deﬁne dissimilarity or “distance” between xi and xj to be
dis0

xi,xj

= the value of a test statistic. (1)
Clearly, dis0(xi,xj) > 0. This dissimilarity measure in (1)
is not the one we actually use when developing cancer
predictivesystems.Infact,wewillusethedissimilarity (1)for
the PAM algorithm only and generate a learnt dissimilarity
measure for the cancer data through combining assignments
from multiple clusterings based on the PAM algorithm. A
learnt measure should be more realistic than that in (1).
This learnt dissimilarity will then be used with a hierarchical
clustering algorithm to produce prognostic systems.
Below we ﬁrst discuss learning dissimilarity from the
use of PAM. And then we present an ensemble clustering
algorithm using the learnt dissimilarity and linkage methods
to develop prognostic systems for cancer patients.
3.1. Learning Dissimilarity from Data. Diﬀerent choices of
dissimilarity functions can lead to quite diﬀerent clustering
results. Prior knowledge is often helpful in selecting an
appropriate dissimilarity measure for a given problem.
However, it is possible to learn a dissimilarity function from
the data. We describe such a procedure as follows.
Partitioning methods are usually not stable in the sense
that the ﬁnal results often depend on initial assignments.
However, if two objects are assigned to the same cluster by
a high percentage of the times of use of the same partitioning
method, it is then very likely that these two objects come
from a common “hidden” group. This heuristic implies that
the“actual”dissimilaritybetweentwoobjectsmaybederived
by combining the various clustering results from repeated
use of the same partitioning technique. Here we formalize
this combining process using the PAM partitioning method.
For the data {x1,x2,...,xn}, we can select K initial
medoids and then run PAM with the dissimilarity measure
(1) to partition the data into K clusters. It is known
that the ﬁnal assignment usually depends on the initial
reallocation. Now we run PAM N times. Each time a number
K is randomly picked from a given interval [K1,K2]. By
doing this, we may end up with N possibly diﬀerent ﬁnal
assignments. Given two objects xi and xj,l e tpij denote the
probability that they are not placed into the same cluster
by the ﬁnal assignment of a run of PAM. This probability
pij can be estimated by using the results of repeated PAM
clustering. Deﬁne δl(i, j) = 1 if the lth use of the PAM
algorithmdoesnotassignxi andxj intothesamecluster;and
δl(i, j) = 0 otherwise. Then δ1(i, j),δ2(i, j),...,δN(i, j)a r e
i.i.d Bernoulli (pij). It is well known that the best unbiased
estimator of pij is
N
l=1δl(i, j)/N. This estimate will be used
as the dissimilarity measure between xi and xj, that is,
dis

xi,xj

=
N
l=1δl

i, j

N
. (2)4 Journal of Biomedicine and Biotechnology
(1) Given N, K1,a n dK2, run the PAM clustering method N times with each K randomly chosen from [K1,K2].
(2) Construct the pairwise dissimilarity measure dis(xi,xj) by using the (2).
(3) Cluster the n objects by applying a linkage method and the dissimilarity measure dis(xi,xj)f r o mS t e p2 .
Algorithm 1: Ensemble algorithm of clustering of cancer data.
Table 1: Lung cancer data of 90,214 patients. Survival time is
measured in months. Here, adeno, squamous, large, and small
represent adenocarcinoma, squamous cell carcinoma, large cell
carcinoma, and small cell carcinoma, respectively.
Patient Survival
time (X)
Stage
(X1)
Grade
(X2)
Histology
(X3)
Gender
(X4)
1 6 4 12s q u a m o u s 1
2 2 4 13l a r g e 1
3 2 4 23s q u a m o u s 1
4 8 12s q u a m o u s 1
5 1 6 33s q u a m o u s 2
6 143 3 2 adeno 2
7 6 33s m a l l 2
8 1 44s m a l l 1
9 9 13a d e n o 2
— — ——— —
— — ——— —
90211 1 1 3 squamous 1
90212 2 1 2 adeno 1
90213 62 2 3 adeno 1
90214 4 4 4 squamous 2
As m a l l e rv a l u eo fd i s ( xi,xj) is expected to imply a bigger
chance that xi and xj come from the same “hidden” group.
3.2. Clustering of Cancer Data. With the learnt dissimilarity
(2) between the combinations, we can choose a clustering
method to form “natural” groups of the combinations. For
ﬂexibility and easy interpretation in practice, we choose a
hierarchical clustering approach. The ﬁnal ensemble algo-
rithm of clustering of cancer data (EACCD) is shown in
Algorithm 1. Here the word ensemble refers to the sequence
of the PAM procedures involved in the method.
Earlyissuesonensembleclusteringwerediscussedin[14]
from the perspective of evidence accumulation. The work in
[15] combined the K-means algorithm and linkage methods
to form an ensemble method of discovering sample classes
using gene expression proﬁles.
4. Results on LungCancer
4.1. Dataset. In this study, we used the SEER data [1]
containing records of lung cancer patients diagnosed from
the year 1988 through 1998 and examined the following
factors: AJCC stage, grade, histological type, and gender. We
considered four factors, X1, X2, X3,a n dX4 that were set to be
stage, grade, histological type, and gender, respectively. For
Table 2: A list of 128 combinations based on factor levels. Here,
adeno, squamous, large, and small represent adenocarcinoma,
squamous cell carcinoma, large cell carcinoma, and small cell
carcinoma, respectively.
Group
name
Stage
(X1)
Grade
(X2)
Histology
(X3)
Gender
(X4)
Sample
size
Comb 1 I 1 adeno 1 1008
Comb 2 I 1 adeno 2 1426
Comb 3 I 1 squamous 1 430
Comb 4 I 1 squamous 2 187
Comb 5 I 1 large 1 8
Comb 6 I 1 large 2 4
Comb 7 I 1 small 1 2
Comb 8 I 1 small 2 2
Comb 9 I 2 adeno 1 2389
Comb 10 I 2 adeno 2 2662
—— — — ——
—— — — ——
Comb 123 IV 4 squamous 1 163
Comb 124 IV 4 squamous 2 70
Comb 125 IV 4 large 1 1503
Comb 126 IV 4 large 2 911
Comb 127 IV 4 small 1 4246
Comb 128 IV 4 small 2 3368
simplicity, we only investigated the following four important
levels of X3: adenocarcinoma, squamous cell carcinoma,
large cell carcinoma, and small cell carcinoma. The levels
of other three variables were those commonly used in the
lung cancer study. Factor X1 had four levels: I, II, III, and
IV; factor X2 had four levels: 1, 2, 3, and 4; and factor X4
had two levels: 1 (male) and 2 (female). The ﬁnal data we
actually used involve 90,214 patients. A portion of the data,
in terms of X(survival time), X1, X2, X3,a n dX4,i sp r o v i d e d
in ]Table 1.
Before running our algorithm EACCD, we used the levels
of four factors X1, X2, X3,a n dX4 to partition the dataset
into 128(= 4 × 4 × 4 × 2) combinations, shown in Table 2.
Due to the approximation of the chi-square distribution to
the log-rank test statistic, a combination containing less than
100 patients was dropped from our study. In this case, no
further analysis was done for these combinations, and our
attention was paid to all the other combinations that have a
size equal to or larger than 100. For example, Comb 5, Comb
6, Comb 7, Comb 8, Comb 124, as shown in Table 2,w e r eJournal of Biomedicine and Biotechnology 5
Table 3: Seven groups produced by cutting the dendrogram in
Figure 1 at the height 0.93.
Group Combinations Sample size
Group 1
Stage I, Grade 1, adeno
11303 Stage I, Grade 2, adeno
Stage I, Grade 2, squamous, female
Stage I, Grade 3, adeno, female
Stage I, Grade 4, adeno, female
Group 2
Stage I, Grade 1, squamous
13431
Stage I, Grade 2, squamous, male
Stage I, Grade 3, adeno, male
Stage I, Grade 3, squamous
Stage I, Grade 3, large cells, female
Stage I, Grade 4, adeno, male
Stage I, Grade 4, large cells
S t a g eI I ,G r a d e1 ,a d e n o ,f e m a l e
S t a g eI I ,G r a d e2 ,a d e n o ,f e m a l e
S t a g eI I ,G r a d e2 ,s q u a m o u s ,f e m a l e
Group 3
Stage I, Grade 1, squamous, male
4522
Stage I, Grade 3, large cells, male
Stage I, Grade 4, squamous, male
S t a g eI I ,G r a d e1 ,a d e n o ,m a l e
S t a g eI I ,G r a d e2 ,a d e n o ,m a l e
S t a g eI I ,G r a d e2 ,s q u a m o u s ,m a l e
S t a g eI I ,G r a d e3 ,a d e n o
S t a g eI I ,G r a d e3 ,s q u a m o u s
S t a g eI I ,G r a d e4 ,l a r g ec e l l s
Group 4
Stage I, Grade 4, small cells
4291 S t a g eI I ,G r a d e4 ,s m a l lc e l l s
S t a g eI I I ,G r a d e1 ,a d e n o
S t a g eI I I ,G r a d e2 ,a d e n o
Group 5
S t a g eI I I ,G r a d e1 ,s q u a m o u s
24951
S t a g eI I I ,G r a d e2 ,s q u a m o u s
S t a g eI I I ,G r a d e3
S t a g eI I I ,G r a d e4 ,a d e n o
Stage III, Grade 4, squamous, male
S t a g eI I I ,G r a d e4 ,l a r g ec e l l s
S t a g eI I I ,G r a d e4 ,s m a l lc e l l s
Group 6
S t a g eI V ,G r a d e1 ,a d e n o ,m a l e
18215
S t a g eI V ,G r a d e1 ,s q u a m o u s ,m a l e
S t a g eI V ,G r a d e2 ,a d e n o
S t a g eI V ,G r a d e2 ,s q u a m o u s ,m a l e
S t a g eI V ,G r a d e3 ,a d e n o ,f e m a l e
S t a g eI V ,G r a d e3 ,s q u a m o u s ,f e m a l e
S t a g eI V ,G r a d e3 ,s m a l lc e l l s
S t a g eI V ,G r a d e4 ,a d e n o
S t a g eI V ,G r a d e4 ,s m a l lc e l l s
Table 3: Continued.
Group Combinations Sample size
Group 7
Stage IV, Grade 2, squamous, female
12237
Stage IV, Grade 3, adeno, male
Stage IV, Grade 3, squamous, male
Stage IV, Grade 3, large cells
Stage IV, Grade 4, squamous, male
Stage IV, Grade 4, large cells
1
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Figure 1: Dendrogram from clustering of lung cancer data.
dropped from our study. Under this restriction we only kept
80 combinations, leaving out a total of 1,264 patients.
4.2. Setting of the Algorithm. To run our algorithm EACCD,
we chose parameters as follows. The choice of N depends on
the rate at which dis in (2)c o n v e r g e st opij. A large number
should be chosen for N, and for this purpose we set N =
10000. Any theoretically possible choices of K was used in
running PAM, and thus we set K1 = 2a n dK2 = 79, due to
availability of 80 objects. In addition, the log-rank test was6 Journal of Biomedicine and Biotechnology
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Figure 2: Survival curves of seven groups in Table 3.
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Figure 3: Survival curves of four TNM stages.
used to obtain the measure (1) for the PAM algorithm. And
the average linkage was employed as a hierarchical clustering
method.
4.3. Results from Cluster Analysis. The output of cluster anal-
ysisforthese80combinationsisshowninFigure 1,wherefor
simplicity Comb has been removed from each combination
orlabel.Itisstraightforwardtousethedendrogramshownin
Figure 1. Cutting oﬀ the dendrogram at a speciﬁed height of
the dissimilarity axis partitions data into disjoint clusters or
groups. Cutting at diﬀerent heights usually leads to diﬀerent
numbers of groups. As an example, if we cut the dendrogram
in Figure 1 at a height slightly above 0.90, then we obtain 7
groups shown in Table 3. The log-rank test shows that any
two groups diﬀer signiﬁcantly (using a signiﬁcance level of
0.01) in their survival functions. Figure 2 shows the Kaplan-
Meier estimates of the survival curves for the 7 groups. These
7 groups and their survival curves constitute a prognostic
systemforlungcancerpatients,asdiscussedinstep(ii)ofthe
Section of Introduction. Prediction using this system is then
carried out in the usual way. In comparison, those 4 survival
curves from the TNM system, based on all the patients from
the 80 combinations, are provided in Figure 3.
Some observations come immediately from Table 3.
Group 1, 5, 6, and 7 only contain some cases from Stage
I, III, IV, and IV, respectively. Both groups 2 and 3 contain
Stage I cancer cases, indicating that additional relevant
parameters are associated with increased relative biologic
aggressive tumor behavior. Group 4 consists of some cases
from Stage I, II, and III, suggesting that localized biologically
aggressive cancers may have the same survival as more
indolent advanced staged cancers.
5. Conclusion
In this paper we have introduced an ensemble clustering
based approach to establish prognostic systems that can be
used to predict an outcome or a survival rate of cancer
patients. An application of the approach to lung cancer
patients has been given.
Generalizing or reﬁning the work presented in this paper
can be done in many ways. Our algorithm EACCD actually is
a two-step clustering method. In the ﬁrst step, a dissimilarity
measure is learnt by using PAM, and in the second step,
the learnt dissimilarity is used with a hierarchical clustering
algorithm to obtain clusters of patients. These clusters of
patients form a basis of a prognostic system. Improvement
of dissimilarity measures (1)a n d( 2), as well as the eﬀect
of diﬀerent algorithms used in each step will be investigated
in our future work. Reﬁned algorithms, based on EACCD,
will be sought and resulting prognostic systems with clinical
applications will be reported. This constitutes our main
research work in the future.
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